Ehren I. Ekhause
Shelley A. Co
Jennifer N. Petras
Jenna R. Margolis
Feng Liu
<p>Feng Liu, MD, PhD, is an attending psychiatrist at the Children’s Hospital at Montefiore Einstein and Assistant Professor, Psychiatry and Pediatrics at our Albert Einstein College of Medicine. Dr. Liu is a child and adolescent psychiatrist whose clinical practice focuses on the diagnosis and treatment of children with psychiatric and behavioral issues. She focuses on providing advanced and reliable diagnostic and pharmacological interventions for children with severe mental health disorders and developmental disabilities.</p><p>After earning her Doctor of Medicine at Tongji Medical University in Wuhan, China, in 1985, Dr. Liu moved to the United States to continue her medical training, earning her Doctor of Philosophy in biology at the State University of New York at Binghamton in 1993. She completed her psychiatry residency at Montefiore Einstein in 2001, followed by a fellowship in child & adolescent psychiatry at New York University School of Medicine, Bellevue Hospital Center, in 2003.</p><p>Dr. Liu’s research focuses on effective psychopharmacological treatment for common comorbid psychiatric disorders, such as attention-deficit/hyperactivity disorder (ADHD) or mood disorders, in developmentally delayed children and adolescents. Her work has been shared through numerous peer-reviewed publications and scientific meetings.</p><p>Dr. Liu is board certified by the American Board of Psychiatry and Neurology in Psychiatry with a subspecialty certification in Child and Adolescent Psychiatry. She is a member of the American Psychiatric Association and the American Academy of Child and Adolescent Psychiatry. Dr. Liu is fluent in English and Chinese.</p>
Asif M. Rahman
<p>Asif M. Rahman, MD, is an attending psychiatrist at Montefiore Einstein and Assistant Professor, Psychiatry and Behavioral Sciences at our Albert Einstein College of Medicine. His clinical areas of focus include bipolar and unipolar mood disorders, anxiety disorders, obsessive-compulsive spectrum disorders, schizophrenia spectrum disorders, trauma and stressor-related disorders, attention-deficit hyperactivity disorders, cluster B personality disorders and autism spectrum disorders.</p><p>After obtaining his Doctor of Medicine from Albert Einstein College of Medicine in 2018, Dr. Rahman completed his residency in adult psychiatry at Nassau University Medical Center in 2021, where he was Chief Resident Physician for Academics and Research in his final year. Following this, Dr. Rahman completed a fellowship in child and adolescent psychiatry at the Icahn School of Medicine at Mount Sinai in 2023.</p><p>Dr. Rahman’s primary research interests focus on the emerging pharmacologic and psychotherapeutic roles of psychedelics such as psilocybin and MDMA, as well as that of ketamine and esketamine in the management of treatment-resistant psychiatric disorders. He has shared his work through scientific publications and multiple presentations.</p><p>Dr. Rahman is board certified by the American Board of Psychiatry and Neurology in Adult Psychiatry and Child and Adolescent Psychiatry. He is a member of the American Academy of Child and Adolescent Psychiatry, the Society of Biological Psychiatry and the American Psychiatric Association. In 2018, Dr. Rahman received the Chair's Choice Award for Early Career Investigators from the Society of Biological Psychiatry. He is Fluent in English, Spanish and Bengali.</p>